Results 301 to 310 of about 144,610 (311)

Biomarkers of residual disease after neoadjuvant therapy for breast cancer

Nature Reviews Clinical Oncology, 2016
Frédérique Penault-Llorca, Nina Radosevic-Robin, Penault-Llorca Frédérique   +2 more
exaly  

RANDOMIZED COMPARATIVE STUDY OF 3 VERSUS 8-MONTH NEOADJUVANT HORMONAL THERAPY BEFORE RADICAL PROSTATECTOMY: BIOCHEMICAL AND PATHOLOGICAL EFFECTS

Journal of Urology, 2001
Martin E Gleave, Joseph L Chin, Fred Saad   +2 more
exaly  

Neoadjuvant Therapy of Lung Cancer

Chest, 1991
openaire   +2 more sources

Neoadjuvant therapy in pancreatic cancer: a systematic review and meta‐analysis of prospective studies

Cancer Medicine, 2017
Han-Xiang Zhan, Jian-Wei Xu, Dong Wu
exaly  

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer

American Journal of Surgery, 2009
Marcus C Tan, Feng Gao, Rebecca L Aft
exaly  

Detecting Pathological Complete Response in Esophageal Cancer after Neoadjuvant Therapy Based on Imaging Techniques: A Diagnostic Systematic Review and Meta-Analysis

Journal of Thoracic Oncology, 2019
Didi J J M De Gouw, Bastiaan R Klarenbeek, Stefan A W Bouwense   +2 more
exaly  

Neoadjuvant Therapy

2009
openaire   +1 more source

Predictive markers of response to neoadjuvant therapy in rectal cancer

Journal of Surgical Research, 2015
Luis Barneo
exaly  

MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy

European Journal of Radiology, 2012
Shotaro Kanao, Tomohisa Okada, Takayuki Ueno   +2 more
exaly  

Neoadjuvant Therapy for Colon Cancer

Diseases of the Colon & Rectum
Lauren Weaver, Paolo Goffredo
openaire   +2 more sources